Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Brewster, Katharine K.a; b; * | Hu, Mei-Chena; b | Wall, Melanie M.a; b | Brown, Patrick J.a; b | Zilcha-Mano, Sigalb; c | Roose, Steven P.a; b | Stein, Alexandraa; b | Golub, Justin S.b | Rutherford, Bret R.a; b
Affiliations: [a] New York State Psychiatric Institute, New York, NY, USA | [b] Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA | [c] University of Haifa, Haifa, Israel
Correspondence: [*] Correspondence to: Katharine K. Brewster, MD, 1051 Riverside Drive, Box 92, New York, NY 10032, USA. Tel.: +1 646 774 6380; Fax: +1 646 774 6398; E-mail: [email protected].
Abstract: Background:Age-related hearing loss (HL) has been associated with dementia, though the neurocognitive profile of individuals with HL is poorly understood. Objective:To characterize the neurocognitive profile of HL. Methods:N = 8,529 participants from the National Alzheimer’s Coordinating Center ≥60 years and free of cognitive impairment who were characterized as Untreated-, Treated-, or No HL. Outcomes included executive function (Trail Making Test [TMT] Part B), episodic memory (Immediate/Delayed Recall), language fluency (Vegetables, Boston Naming Test), and conversion to dementia. Regression models were fit to examine associations between HL and neurocognitive performance at baseline. Cox proportional hazards models examined the links between HL, neurocognitive scores, and development of dementia over follow-up. Results:At baseline, those with Untreated HL (versus No HL) had worse neurocognitive performance per standardized difference on executive function (TMT Part B [mean difference = 0.05 (95% CI 0.00, 0.10)]) and language fluency (Vegetables [mean difference = –0.07 (95% CI –0.14, –0.01)], Boston Naming Test [mean difference = –0.07 (95% CI –0.13, –0.01)]). No differences in these neurocognitive performance scores were demonstrated between Treated HL and No HL groups other than MMSE [mean difference = –0.06 (95% CI –0.12, 0.00)]. Through follow-up, executive dysfunction differed by hearing group (χ2(2) = 46.08, p < 0.0001) and was present among 39.12% in No HL, 44.85% in Untreated HL, and 49.40% in Treated HL. Worse performance across all cognitive domains predicted incident dementia. Conclusion:The observed association between Untreated HL and lower cognitive ability that improved when hearing aids were worn may reflect an inability to hear the test instructions. Future studies using cognitive assessments validated for use in HL are needed to evaluate the neuropsychological profile of HL and identify individuals at risk for dementia.
Keywords: Alzheimer’s disease, cognitive dysfunction, dementia, hearing loss, neuropsychological tests
DOI: 10.3233/JAD-200908
Journal: Journal of Alzheimer's Disease, vol. 80, no. 2, pp. 855-864, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]